Skip to main content
SpringerLink
Log in

A combination of calcitonin and bisphosphonate for the emergency treatment of severe tumor-induced hypercalcemia

  • Letter to the Editor
  • Published:
Calcified Tissue International Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Subscribe and save

Springer+ Basic
$34.99 /Month
  • Get 10 units per month
  • Download Article/Chapter or eBook
  • 1 Unit = 1 Article or 1 Chapter
  • Cancel anytime
Subscribe now

Buy Now

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Ralston SH, Patel U, Fraser WD, Gallacher SJ, Dryburgh FJ, Cowan RA, Boyle IT (1989) Comparison of three intravenous bisphosphonates in cancer-associated hypercalcaemia. Lancet ii: 1180–1182

    Google Scholar 

  2. Gucalp R, Ritch P, Wiernik PH, Sarma PR, Keller A, Richman SP, Tauer K, Neidhart J, Mallette LE, Siegel R, Vandepol CJ (1992) Comparative study of pamidronate disodium and etidronate disodium in the treatment of cancer-related hypercalcemia. J Clin Oncol 10:134–142

    Google Scholar 

  3. Morton AR, Friefeld J, Halperin F (1990) Dose of bisphosphonate for hypercalcemia of malignancy. Lancet ii:1469–1470

    Google Scholar 

  4. Thiébaud D, Jaeger Ph, Jacquet AF, Burckhardt P (1988) Dose-response in the treatment of hypercalcemia of malignancy by a single infusion of the bisphosphonate AHPrBP. J Clin Oncol 6:762–768

    Google Scholar 

  5. Morton AR, Cantrill JA, Craig AE, Howell A, Davies M, Anderson DC (1988) Single dose versus daily intravenous aminohy-droxypropylidene bisphosphonate (APD) for the hypercalcaemia of malignancy. Br Med J 296:811–814

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Medicine, Queen's University, K7L 3N6, Kingston, Ontario, Canada

    Kiersten Luce, Denis E. O'Donnell & A. Ross Morton

Authors
  1. Kiersten Luce
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Denis E. O'Donnell
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. A. Ross Morton
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Luce, K., O'Donnell, D.E. & Morton, A.R. A combination of calcitonin and bisphosphonate for the emergency treatment of severe tumor-induced hypercalcemia. Calcif Tissue Int 52, 70–71 (1993). https://doi.org/10.1007/BF00675630

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00675630

Keywords

Search

Navigation